In placental/umbilical cord blood (PCB) banking and PCB transplantation (PCBT), long-term cryopreservation of hematopoietic stem and progenitor cells is a unique requirement as compared to that for bone marrow transplantation and cytokine-mobilized peripheral blood transplantation. A long period of severe thrombocytopenia is a problem in many patients after PCBT. The object of this study was to define whether megakaryocytic progenitor cells (CFU-Meg), which produce platelets, are more sensitive to cryopreservation than the other myeloid progenitor cells in PCB. The leukocyte concentrates (LCs) obtained from clinical PCB banks were cryopreserved, and progenitor cell recoveries were determined by differential count of colony-forming cells (CFCs). The LCs were exposed to stresses which cells face during freezing, thawing, and washing out cryoprotectants. Most of the myeloid progenitor cells contained in the LCs showed good survival when cryopreserved at slow cooling rates, although cellular injury was observed at higher cooling rates and higher osmolalities. In contrast, the recovery rate of CFU-Meg was significantly lower than other progenitor cells, indicating a higher sensitivity to the various stresses they were exposed to during cryopreservation. Thrombocytopenia observed in patients receiving PCBT may be explained, at least in part, by the disappearance of CFU-Meg during cryopreservation.
cryopreservation; leukocyte concentrates Placental/umbilical cord blood (PCB) has been increasingly used as a source of hematopoietic stem and progenitor cells for transplantation in patients for whom no suitable bone marrow (BM) donor can be found. [1] [2] [3] [4] [5] [6] The clinical outcomes obtained following PCB transplantation (PCBT) have been reported to be as good as those following bone marrow transplantation (BMT). 7, 8 PCBT has several advantages over allogenic BMT: 9, 10 It is associated with a lower risk of severe graft-versus-host disease and clinically important viral infections, successful transplantation is possible even using partial human leukocyte-associated antigen mismatches, and there are no risks associated with BM donors. On the other hand, despite the advantages of PCBT over BMT, several disadvantages must also be considered. Slow recovery of neutrophils and platelets in the recipients is one of them, 5 even though some studies have reported conflicting results, that is, that the time for platelet engraftment is similar to those observed after BMT from unrelated donors. [11] [12] [13] One possible reason for the late platelet recovery is that megakaryocyte colony-forming units (CFU-Meg), which are the progenitor cells of megakaryocytes and control platelet production, are more immature in PCB than those in BM or peripheral blood (PB), although these characteristics are not yet clearly understood. PCBT differs from bone marrow and cytokinemobilized PB stem cell transplantation in many respects. The most distinct difference is the necessity for long-term cryopreservation of PCB units prior to the transplantation. Therefore, there is a possibility that CFU-Meg are probably more sensitive to freezing injury than the other myeloid colony-forming cells (CFC) in PCB, including erythroid burst-forming units (BFU-E), granulocytemacrophage colony-forming units (CFU-GM), and mixed colony-forming units (CFU-Mix). The detailed mechanism of freezing injury during the cryopreservation of hematopoietic progenitor cells in PCB has still not been studied as well as those of the cells in BM and PB. The freezing protocols of these hematopoietic progenitor cells have been determined on the basis of experience, recoveries of cells in vitro, and the results of transplantation in vivo, that is, the engraftment of blood cells after transplantation.
In this study, leucocyte concentrates (LCs) obtained from clinical PCB banks after removal of blood cells and plasma from blood were cryopreserved under different conditions, such as different cooling rates, in order to determine the sensitivity of the cells to freezing injuries. It was found that CFU-Meg are considerably more sensitive to freezing injuries than other CFC.
Design and methods

Collection of PCB
After obtaining informed consent from the mothers, PCB was collected at the end of full-term deliveries in sterile collection bags containing the anticoagulant citrate-phosphate dextrose, in accordance with the standard procedures of the Tokyo Cord Blood Bank.
Leukocyte separation
LCs containing progenitor cells were collected in accordance with the New York Blood Center's protocol. 7 Briefly, one-fourth of the whole blood volume of 6% hydroxyethyl starch (HESPAN, DuPont Pharma, Wilmington, DE, USA) was gently added to the collected blood, which was then centrifuged at 150 g for 5 min at 201C. The supernatant was recentrifuged at 400 g for 5 min, and the sedimented cells were collected as the LCs.
Cryoprotectants
Cryoprotectant solution (50% dimethyl sulfoxide (DMSO; Cryoserve, Research Industries, Salt Lake City, UT, USA) and 10% Dextran 40 (Dextran, Yoshitomi Pharm, Osaka, Japan)) was added to the LCs dropwise, while rotating the cell suspension gently, to a final concentration of 10 and 1%, respectively.
Standard freezing procedure
The LCs in cryogenic vials were placed in a freezing container, Bicell (Nihon Freezer, Tokyo, Japan), which was placed in a À1351C mechanical freezer (MDF-2136AT, SANYO, Tokyo, Japan) or in a programmable freezer (CryoMed, Forma Science, Marietta, OH, USA), and cooled at the cooling rate of 21C/min, to À801C, and then stored in liquid nitrogen (LN 2 ) for 7 days, on average. The cooling rate was measured by the cupper-constantin thermocouple (Tokyo Wire, Tokyo, Japan) connected to the recorder (Chino 22005, Tokyo, Japan).
Standard thawing and washing procedures
After rapid thawing in a 371C water bath, 1/2 of the cell volume of a washing solution composed of 10% Dextran 40 and 1/2 of the cell volume of 5% human serum albumin (HSA, Kaketsuken, Kumamoto, Japan) were added dropwise to the LCs at room temperature. They were allowed to stand for 5 min and then centrifuged at 400 g at 101C for 10 min. The supernatant was removed, while leaving 1 ml of cell suspension, which was then resuspended with the same volume of 5% Dextran 40 and 2.5% HSA medium. After centrifugation again under the same conditions, the cells were resuspended in the washing medium.
Cooling rate effect
For the cooling rate experiment, the LCs containing cryoprotectants were frozen at À2, À5, À10, À30, À501C/ min in a programmable freezer to À801C. When the LCs were cooled to around À51C, they were forced to freeze extracellularly by exposure to an excess of LN 2 , and then cooled to the target temperatures.
Plunging into LN 2
The LCs containing cryoprotectants were frozen at the rate of 21C/min to À30, À40, À50, and À801C, then immediately plunged into LN 2 .
Osmotic stress
The freshly prepared LCs were exposed to osmotic stress in phosphate-buffered saline (PBS, 6.7 mM KH 2 PO 4 -Na 2 HPO 4 buffer, pH 7.4), the osmolality of which was increased by the addition of sodium chloride from 300 to 1500 mOsm. The osmolality was measured by an osmometer (Roebling Hermann, Messtechnik, Germany). Cells (5 Â 10 6 ) were suspended in 2 ml of hypertonic or hypotonic medium for 10 min at 01C in an ice water bath. After the exposure to osmotic stress, hypertonic or hypotonic solution was added to resuspend the cells in isotonic osmolality.
Dilution shock
As a control experiment, an equal volume of the standard washing solution (10% Dextran 40 and 5% HAS) was slowly added to the cryopreserved LCs loaded with 10% DMSO and the mixture was allowed to stand at room temperature for 5 min. Half of the volume of the supernatant was removed by aspiration, and then the sedimented cells were resuspended with twice the volume of the washing solution. The cells were centrifuged at 101C for 5 min at 400 g, and resuspended. Under the same experimental conditions, the thawed LCs were added to PCB plasma obtained by centrifugation of the PCB at the dilution rate (LC: plasma, v/v) of 5, 20, and 100, and the two were mixed rapidly at room temperature and left to stand for 5 min. After this treatment, standard washing solution was added slowly to the cells at 10 times the volume to avoid further dilution shock.
Chilling effect
For the chilling experiment, the freshly prepared LCs were exposed in an ice-water bath as 01C treatment or incubated in a refrigerator (Sanyo, Japan) programmed at 241C for 24 and 48 h.
Viability assay and cell counting
Cell viability was measured by staining the cells with ethidium bromide and acridin orange (AcOr). The staining solution and cell suspensions were mixed in equal volumes (final concentration: ethidium bromide, 0.001%, AcOr, 0.0003%), and the cells were observed under FACS Calibur (Becton Dickinson Bioscience, Franklin Lakes, NJ, USA). The cell numbers were counted manually in a hemocytometer or using an automated cell counter (Counter MD18, Coulter, Miami, FL, USA).
Growth factors and reagents
Recombinant human thrombopoietin (TPO), stem cell factor (SCF), interleukin-3 (IL-3), and IL-6 were kindly provided by KIRIN Brewery (Tokyo, Japan). Recombinant human granulocyte colony-stimulating factor (G-CSF) and erythropoietin (Epo) were purchased from Sankyo (Tokyo, Japan). Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was purchased from Biosource (Camarillo, CA, USA). Flt3/ Flk2-ligand (FL) was purchased from Gibco BRL (Grand Island, NE, USA). The amounts of these factors added per milliliter of the medium were: TPO, 50 ng; SCF, 100 ng; IL-3, 5 ng; IL-6, 5 ng; G-CSF, 5 ng; GM-CSF, 20 ng; Epo, 4 U; FL, 100 ng. A mixture of SCF, IL-3, G-CSF, GM-CSF, and Epo was used as a source of stimulants in methylcellulose culture. In the case of plasma clot culture, a mixture of TPO, SCF, IL-3, IL-6 and FL was added to the culture.
Methylcellulose colony assay
Colony-forming cells, including BFU-E, CFU-GM, and CFU-Mix, were assayed using a methylcellulose culture, as described previously, with minor modifications. 14, 15 LCs at a concentration of 1 Â 10 4 were plated in 35-mm plastic Petri-dishes (Falcon, Becton Dickinson Bioscience, Franklin Lakes, NJ, USA) in 1 ml MethoCult (H4434 V, Veritas, Tokyo, Japan) medium containing a mixture of growth factors. Each dish was incubated at 371C in a humidified atmosphere containing 5% CO 2 for 14 days. Colonies containing more than 50 cells were counted under an inverted microscope.
Plasma clot culture
CFU-Meg were assayed by the plasma clot technique using platelet-poor human plasma. 16 The culture medium contained 15-20% human platelet-poor AB plasma plus growth factors in Iscove's modified Dulbecco's medium (Gibco BRL). Other additives used were penicillin (100 U/ ml), streptomycin (100 mg/ml), sodium pyruvate (1 mM), MEM vitamin (1%), and MEM nonessential amino acids (1%) (all from Gibco BRL), thioglycerol (1 Â 10 À5 M) (Sigma, St Louis, USA), L-asparagine (2 mg/ml), and CaCl 2 (74 mg/ml) (both from Wako Pure Chemicals, Tokyo, Japan), and 0.2% bovine serum albumin (BSA, Boehringer Mannheim GmbH, Germany). The LCs were added to the culture medium at the concentration of 2 Â 10 5 /ml. This baseline culture was plated onto 24-well cell culture plates (Falcon) at 0.3 ml/well, and incubated at 371C for 11-12 days in a humidified atmosphere containing 5% CO 2 .
Immunofluorescence staining to identify megakaryocyte colonies
Each well was fixed twice with a 2:1 mixture of acetone and methanol for 15 min. The plates were dried under airflow overnight and then stored at À201C until staining. For the staining, the plates were taken out of the freezer and returned to room temperature. Then, PBS containing 0.5% BSA (PBS-B) was added to soften the clot. The solution was discarded, fluorescein-isothiocyanate-conjugated antihuman CD41a (GPIIbIIIa, Pharmingen, San Diego, CA, USA) antibody diluted 1:100 in PBS-B was added, and the plates were incubated for 1 h at room temperature. The plates were washed and the nuclei were counterstained with propidium iodine (0.3 ng/ml, Sigma). The colonies were washed again and counted under a fluorescence microscope (Olympus, Tokyo, Japan) at a magnification of Â 100. The megakaryocyte colonies were classified into two types: large colonies of more than 50 cells (immature CFU-Meg), and small colonies containing 3-50 cells (mature CFUMeg). 17, 18 The total number of CFU-Meg (total CFU-Meg) was obtained by adding the number of immature CFUMeg and mature CFU-Meg.
Statistical analysis
The significance of differences between the control and experimental groups were determined by Student's t-test.
Results
Recoveries of CFC and CFU-Meg after cryopreservation
The contents of CFC and CFU-Meg in cryopreserved LCs were assayed by the methylcellulose culture and the plasma clot culture methods (Figure 1) . The total recovery rates of CFC and CFU-Meg after freezing and thawing were 82.879.9 and 53.3722.5%, respectively (Po0.001), indicating that CFU-Meg were more sensitive to the stresses of cryopreservation than CFC. No statistically significant differences were observed among the recovery rates of BFU-E (84.5713.2%), CFU-GM (77.0715.3%), and CFU-Mix (64.6716.4%) that constitute CFC. In contrast, the recovery rate of immature CFU-Meg (40.7726.0%) that form large megakaryocyte colonies was significantly lower than that of mature CFU-Meg (74.6728.2%) (Po0.001), indicating that immature CFU-Meg were more sensitive as compared to mature CFU-Meg to the stresses of freezing.
Effect of cooling rate
To determine the effect of cooling rate on the clonal growth of CFC and CFU-Meg, the LCs were frozen at various cooling rates. The recoveries of both CFC and CFU-Meg decreased as the cooling rates increased (Figure 2 ). There was no statistically significant difference in the sensitivity to the cooling rate between CFC and CFU-Meg, and the recoveries of both dropped to less than 30% at 101C/min, and 5% at 501C/min. In regard to CFC, there were no significant differences among the recoveries of CFU-GM, BFU-E, and CFU-Mix (data not shown). A slow cooling rate of 21C/min was found to be optimal for the recovery of progenitor cells in our study.
Effect of plunging temperature
The LCs were frozen at the rate of 21C/min to À30, À40, À50, and À801C and plunged into LN 2 ( Figure 3) , and the clonogenic potential of each hematopoietic progenitor cell type was estimated. CFU-Meg were influenced most by this plunging temperature effect, and only about 60% of CFUMeg were recovered when the cells were cooled to À501C and plunged into LN 2 . Although no significant difference was observed between CFC and CFU-Meg, CFU-Meg showed a tendency towards higher sensitivity when exposed to the same plunging temperature. When the plunging temperature was À301C, the recoveries of CFC and CFU-Meg decreased to 53.4723.5 and 28.5714.8%, respectively.
Effect of osmotic stress
To examine the effect of osmotic stress on the colonyforming ability of CFC and CFU-Meg, the freshly prepared LCs were exposed to various osmotic conditions, from 300 to 1500 mOsm ( Figure 4 ). The total recovery rate of CFU-Meg decreased to a significantly greater extent following exposure to 900 mOsm as compared with that of CFC. Following exposure to 900, 1200, and 1500 mOsm, the recovery rates of CFU-Meg were 27.3, 12.5 and 3.7%, respectively, which were a statistically significant difference as compared with those of CFC. 
Effect of dilution shock
Experiments to test the sensitivity of cells to dilution shock (when they are exposed to during thawing and removal of the cryoprotectants before infusion of the cryopreserved cells) were carried out. The LCs loaded with cryoprotectants were rapidly diluted with different volumes of PCB plasma. With increasing dilution, the extent of cell damage also increased ( Figure 5 ). However, there was no statistically significant difference in the sensitivity to dilution shock between CFC and CFU-Meg. There were also no differences in the sensitivity to dilution shock among CFU-GM, BFU-E, and CFU-Mix (data not shown).
Effect of chilling
To determine the effects of chilling on the clonal growth of hematopoietic progenitor cells, the freshly prepared LCs were exposed to 24 or 01C for 24 and 48 h to find the sensitivity of the progenitor cells to low temperatures above freezing. No statistically significant differences were observed in among the viabilities of the cells obtained from the chilling experiment (data not shown). The recoveries of CFC and CFU-Meg were not significantly different when they were stored at 241C for 48 h, even though the recovery rate of both decreased to about 90% ( Figure 6 ). When the cells were stored at 01C for 24 or 48 h, the recovery of CFUMeg decreased to 75.0 and 60.9%, respectively, which was significantly different statistically as compared to CFC. CFU-Meg showed a greater sensitivity to chilling at 01C as compared to other CFC.
Discussion
In PCB banking and PCBT, long-term cryopreservation of hematopoietic stem and progenitor cells is a unique requirement as compared to that for BMT and cytokinemobilized PB transplantation. 19 However, little is known about the impact of cryopreservation on the cellular characteristics of each hematopoietic progenitor cell contained in PCB, especially on CFU-Meg. Therefore, there are few studies on the correlation between the changes in the characteristics of CFU-Meg during cryopreservation and prolonged severe thrombocytopenia after PCBT. In the present study, while the overall recovery rates of CFC (82.879.9%) after cryopreservation were reasonable (Figure 1) , CFU-Meg (53.3722.5%) were found to be more sensitive to the stresses of cryopreservation than other progenitor cells. In addition, the recovery rates of immature CFU-Meg and mature CFU-Meg after cryopreservation were 40.7 and 74.6%, respectively. Our results demonstrated that immature CFU-Meg, which possess high proliferative capacities and constitute a high proportion of the cells in PCB to produce a large number of megakaryocytes, were especially sensitive to the stresses of cryopreservation.
Woods et al 20 reported the osmometric and permeability characteristics of PCB CD34 þ cells by monitoring the cell volume changes with an electronic particle counter. They exposed CD34 þ cells to hypotonic and hypertonic PBS to examine the sensitivity of the cells to these osmotic stresses. The colony-forming abilities of each of the progenitor cells, including CFU-E, BFU-E, CFU-GM, and CFU-GEMM, dropped sharply at osmolalities lower or higher than that in the isosmotic condition, but no obvious differences in colony-forming ability were observed among the various CFC. They also reported that the osmotic tolerance limits were 200 and 600 mOsm/kg. These findings are consistent with our results. The proliferative capacity of CFU-Meg, however, dropped sharply following exposure to beyond 900 mOsm, indicating a statistically significant difference from the results obtained for CFC (Figure 4 ). On the other hand, no significant differences in the ability for the clonal growth of CFC and CFU-Meg were observed following exposure to the various extracellular stresses, such as a high cooling rate, plunging temperatures, and high dilution (Figures 2, 3 and 5) . Hunt et al 21 also reported that optimal recovery of CD34 þ cells from PCB requires serial addition of DMSO, slow cooling at rates between 1 and 2.51C/min and serial elution of the cryoprotectant after thawing. The precise mechanism of this high sensitivity of CFU-Meg is still unknown at this time. However, Crowe et al 22 have reported that chilling-induced activation of human blood platelets can be ascribed, at least in part, to a thermotropic phase transition in the membrane lipids. In our case, CFUMeg showed a greater sensitivity to chilling at 01C as compared to other CFC ( Figure 6 ). It is possible that their finding may be related to the high cryosensitivity of CFUMeg observed in our study.
Although PCB contains a higher number of CFU-Meg as compared to BM or cytokine-mobilized PB, 23 a significant delay in platelet recovery has been observed in patients receiving PCBT. 24, 25 In contrast, previous reports have shown a correlation between the number of CFU-Meg and the time to platelet engraftment following BMT and PB transplantation. 26, 27 This is possibly because the frequencies of CFU-Meg in individual PCB units vary widely. 23 In addition, the vast majority of PCB samples, in contrast to PB and BM, contained a high number of primitive CFUMeg with high proliferative potential. 28, 29 Furthermore, Miyazaki et al 30 reported that delayed recovery of the platelet count after PCBT might be caused by defects in the megakaryocytic differentiation pathway of PCB progenitors. The proliferative responses of the progenitors in PCB are higher than those in BM cells in the presence of IL-3, SCF, and TPO. However, the ability to generate mature megakaryocytes was higher for BM progenitors than for the progenitors in PCB in the same in vitro culture system, when examined in terms of the expression of CD41, polyploidy, and pro-platelet formation.
Most PCB banks now use the methods of Rubinstein et al, 7 a technique of hydroxyethyl starch sedimentation. Their protocol is a well-standardized cost-efficient method and was reported to yield satisfactory clinical outcomes. 8 In the future, while considering the promotion of megakaryopoiesis and thrombopoiesis after PCBT, it will be necessary to also take into consideration prevention of the disappearance of CFU-Meg during the cryopreservation process. Pick et al 31 reported that during the cryopreservation of whole PCB, the recoveries of hematopoietic progenitor cells after thawing decreased dramatically due to red blood cells lysis and clumping of red cell ghosts. In their report, CFU-Meg-enriched PCB mononuclear cells were isolated by sedimentation on gelatin followed by centrifugation with Ficoll-Hypaque. These PCB mononuclear cells showed high cell viability and excellent proliferation of both megakaryocytes and CFU-Meg, as well as maintenance of other progenitor cells after cryopreservation. Various issues in PCB processing should be investigated for application of PCB banking in the future.
We can reasonably conclude that the thrombocytopenia observed in patients receiving PCBT can be explained, at least in part, by the disappearance of CFU-Meg during cryopreservation.
